Straumann Holding AG (SAUHY)
13.25
-0.30
(-2.25%)
USD |
OTCM |
May 17, 16:00
Straumann Total Liabilities (Quarterly): 1.766B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.766B |
| June 30, 2023 | 1.700B |
| June 30, 2023 | 1.700B |
| December 31, 2022 | 1.639B |
| June 30, 2022 | 1.505B |
| June 30, 2022 | 1.505B |
| December 31, 2021 | 1.605B |
| June 30, 2021 | 1.572B |
| June 30, 2021 | 1.572B |
| December 31, 2020 | 1.532B |
| June 30, 2020 | 1.181B |
| June 30, 2020 | 1.181B |
| December 31, 2019 | 1.056B |
| June 30, 2019 | 1.001B |
| June 30, 2019 | 1.001B |
| December 31, 2018 | 670.61M |
| June 30, 2018 | 624.90M |
| June 30, 2018 | 624.90M |
| December 31, 2017 | 636.41M |
| June 30, 2017 | 556.81M |
| June 30, 2017 | 556.81M |
| Date | Value |
|---|---|
| December 31, 2016 | 448.37M |
| June 30, 2016 | 472.04M |
| June 30, 2016 | 472.04M |
| December 31, 2015 | 446.49M |
| June 30, 2015 | 505.37M |
| June 30, 2015 | 505.37M |
| December 31, 2014 | 428.74M |
| June 30, 2014 | 441.38M |
| June 30, 2014 | 441.38M |
| December 31, 2013 | 437.60M |
| June 30, 2013 | 380.23M |
| June 30, 2013 | 380.23M |
| December 31, 2012 | 191.93M |
| June 30, 2012 | 172.16M |
| June 30, 2012 | 172.16M |
| December 31, 2011 | 183.44M |
| June 30, 2011 | 153.32M |
| December 31, 2010 | 169.31M |
| June 30, 2010 | 158.87M |
| December 31, 2009 | 161.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.001B
Minimum
Jun 2019
1.766B
Maximum
Dec 2023
1.434B
Average
1.532B
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 25.05M |
| CRISPR Therapeutics AG | 355.08M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 6.557M |
| Molecular Partners AG | 26.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.955B |
| Shareholders Equity (Quarterly) | 2.186B |
| Debt to Equity Ratio | 0.1089 |
| Current Ratio | 1.947 |
| Net Debt Paydown Yield | -0.31% |